Chhatwal J, Kanwal F, Roberts MS, Dunn MA. Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States. Ann Intern Med.
Ottersen T, Norheim OF, Chitah BM, et al. Making fair choices on the path to universal health coverage. Bull World Health Organiz. 2014;92(6):389.
Daniels N, Charvel S, Gelpi AH, Porteny T, Urrutia J. Role of the courts in the progressive realization of the right to health: between the threat and the promise of judicialization in Mexico. Health Sys Ref. 2015;1(3):229-234.
Williams I. Institutions, cost-effectiveness analysis and healthcare rationing: the example of healthcare coverage in the English National Health Service. Policy Polit. 2013;41(2):223-239.
International Decision Support Initiative (iDSI) website. http://www.idsihealth.org/. Accessed September 16, 2016.
European Network on Health Technology Assessment (EUnetHTA) website. http://www.eunethta.net/
. Accessed September 16, 2016.
Baltussen R, Jansen MP, Mikkelsen E, et al. Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness. Int J Health Policy Manag.
Daniels N. Accountability for reasonableness. BMJ. 2000;321(7272):1300-1301.
Baroe K, Baltussen R. Legitimate healthcare limit setting in a real-world setting: integrating accountability for reasonableness and multi-criteria decision analysis. Public Health Ethics.
Gibson J, Mitton C, Martin D, Donaldson C, Singer P. Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy.